An experimental MS therapy given as a nasal spray has started dosing its final participant in a Phase 2a trial of people with ...

MMR and chickenpox vaccines don't raise relapse risk for people with MS, a study found, supporting current vaccination ...

Sanofi/Ad Scientiam presented an interim analysis from the ongoing MS-DETECT (NCT05816122) study, showing that Microsoft (MS) ...

Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...

Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...

Sanofi said it received European Union approval for Cenrifki, a new multiple sclerosis medicine, after U.S. regulators ...

India, June 28 -- Multiple sclerosis (MS) affects much more than physical health, often disrupting people's social lives, ...

Multiple sclerosis is especially destructive because of its tendency to worsen progressively. Instead of working through the immune system, Quantum BioPharma’s Lucid-MS acts directly on the myelin ...

People with multiple sclerosis (MS) often face higher unemployment rates. Understanding the challenges and available support can help you navigate employment and financial stability. Many people ...

The Anne Arundel County resident recently announced his retirement because of complications surrounding a multiple sclerosis ...